Summitry LLC grew its stake in Novanta Inc. (NASDAQ:NOVT – Free Report) by 40.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,759 shares of the technology company’s stock after purchasing an additional 508 shares during the quarter. Summitry LLC’s holdings in Novanta were worth $269,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Empowered Funds LLC bought a new position in Novanta in the fourth quarter worth about $26,000. SBI Securities Co. Ltd. purchased a new position in shares of Novanta during the 4th quarter worth approximately $97,000. Venturi Wealth Management LLC raised its position in shares of Novanta by 6,500.0% in the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the technology company’s stock worth $111,000 after acquiring an additional 715 shares in the last quarter. Associated Banc Corp purchased a new position in shares of Novanta in the 3rd quarter valued at approximately $209,000. Finally, Hardy Reed LLC purchased a new position in shares of Novanta in the 3rd quarter valued at approximately $211,000. 98.35% of the stock is owned by hedge funds and other institutional investors.
Novanta Stock Down 0.5 %
Shares of Novanta stock opened at $136.82 on Wednesday. Novanta Inc. has a 1 year low of $131.03 and a 1 year high of $187.12. The firm has a market cap of $4.92 billion, a price-to-earnings ratio of 81.93 and a beta of 1.34. The company has a 50-day moving average of $143.90 and a 200 day moving average of $159.28. The company has a debt-to-equity ratio of 0.61, a current ratio of 2.79 and a quick ratio of 1.81.
Analysts Set New Price Targets
Separately, Robert W. Baird reduced their price target on Novanta from $169.00 to $160.00 and set a “neutral” rating on the stock in a research note on Monday, March 3rd.
Get Our Latest Stock Report on NOVT
About Novanta
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Further Reading
- Five stocks we like better than Novanta
- Insider Trading – What You Need to Know
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Top Biotech Stocks: Exploring Innovation Opportunities
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- Using the MarketBeat Stock Split Calculator
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.